|
![]() |
|||
|
||||
OverviewAlthough monotherapy is generally recommended as the treatment of choice, treatment resistance of patients with psychosis, cognitive, mood and anxiety disorders represents a significant clinical problem. In this context, augmentation and combination strategies are commonly employed to address this problem. Although multiple medication use common in psychiatric practice, reasons, efficacy and safety for polypharmacy, and augmentative strategies have remained unclear. It remains unclear if there is an evidence base to support polypharmacy. Furthermore, excessive and inappropriate use of psychotropic medications has been recognized as a public health problem. This volume is the first comprehensive, clinically oriented, reference on the multiple medication use to treat psychotic, cognitive, mood and anxiety disorders. Full Product DetailsAuthor: Michael S RitsnerPublisher: Springer Imprint: Springer Edition: 2013 ed. Dimensions: Width: 15.50cm , Height: 2.50cm , Length: 23.50cm Weight: 6.944kg ISBN: 9789400757981ISBN 10: 9400757980 Pages: 321 Publication Date: 02 March 2013 Audience: Professional and scholarly , Professional & Vocational Format: Hardback Publisher's Status: Active Availability: Manufactured on demand ![]() We will order this item for you from a manufactured on demand supplier. Table of Contents1. Antipsychotic polypharmacy for schizophrenia: 'Secret sauce' or 'wild abandon'?.- Antipsychotic polypharmacy in USA.- Antipsychotic polypharmacy in Czech Republic and in Ukraine.- Antipsychotic polypharmacy in residential facilities in Italy: the gap between recommendations and real world practice.- Antipsychotic polypharmacy and associated phenomena in patients with schizophrenia: Rational or irrational?.- Antipsychotic polypharmacy in schizophrenia. How to counteract this common practice?.- Clozapine combinations in treatment-resistant schizophrenia patients.- Metabolic syndrome and antipsychotic polypharmacy.- Evidence based combination therapy for bipolar disorder.- Antidepressant combination strategies for major depressive disorder.- Herbal remedies and nutraceuticals as augmentation or adjunct for mood and anxiety disorders: evidence for benefit and risk.- Obsessive-compulsive syndromes in schizophrenia: A case for polypharmacy?.- Polypharmacy and potentially inappropriatemedication use among elders with dementia.- The role of polypharmacy in bipolar disorder treatment guidelines.ReviewsFrom the reviews: The intent is to bring together a compendium of information from both clinical research and experience regarding the ever-increasing use of polypharmacy in the treatment of psychiatric conditions. ... should be read by anyone involved in the pharmacological management of psychiatric illnesses. (Michael Easton, Doody's Book Reviews, July, 2013) From the reviews: The intent is to bring together a compendium of information from both clinical research and experience regarding the ever-increasing use of polypharmacy in the treatment of psychiatric conditions. ... should be read by anyone involved in the pharmacological management of psychiatric illnesses. (Michael Easton, Doody's Book Reviews, July, 2013) Author InformationTab Content 6Author Website:Countries AvailableAll regions |